Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 80,145 |
|
|||||
| News | - | ||||||
| Day High | 2.55 | Low High |
|||||
| Day Low | 2.36 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| bioAffinity Technologies Inc | BIAF | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.05 | -2.04% | 2.40 | 18:08:57 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.49 | 2.36 | 2.55 | 2.40 | 2.45 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 320 | 80,145 | US$ 2.43 | US$ 194,408 | - | 0.9548 - 3.62 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:37:42 | 3 | US$ 2.34 | USD |
bioAffinity Technologies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 22.81M | 9.50M | - | 2.53M | -7.94M | -0.84 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
bioAffinity Technologies News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/24/2024 | 07:00 | Business Wire | bioAffinity Technologies Advances New Product Development.. |
| 4/09/2024 | 07:00 | Business Wire | bioAffinity Technologies Expands Campaign to Support.. |
| 4/01/2024 | 08:49 | Business Wire | bioAffinity Technologies Reports Fourth Quarter and Full.. |
| 3/08/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/08/2024 | 12:15 | PR Newswire (US) | Wallachbeth Capital Announces Closing of bioAffinity.. |
| 3/08/2024 | 11:45 | Business Wire | bioAffinity Technologies Announces Closing of $2.5 Million.. |
| 3/08/2024 | 11:18 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 3/07/2024 | 20:57 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 3/06/2024 | 09:45 | PR Newswire (US) | WallachBeth Capital Announces Pricing of BioAffinity.. |
| 3/06/2024 | 08:46 | Business Wire | bioAffinity Technologies Announces Pricing of $2.5 Million.. |
| 3/05/2024 | 16:26 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 07:00 | Business Wire | bioAffinity Technologies Reports Accelerating Sales Growth.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIAF Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.52 | 2.66 | 2.31 | 2.44 | 93,268 | -0.12 | -4.76% |
| 1 Month | 2.15 | 3.1626 | 2.06 | 2.63 | 202,008 | 0.25 | 11.63% |
| 3 Months | 1.55 | 3.62 | 1.39 | 2.34 | 251,136 | 0.85 | 54.84% |
| 6 Months | 1.32 | 3.62 | 1.22 | 2.29 | 125,745 | 1.08 | 81.82% |
| 1 Year | 1.87 | 3.62 | 0.9548 | 2.24 | 67,735 | 0.53 | 28.34% |
| 3 Years | 8.40 | 15.55 | 0.9548 | 3.86 | 621,337 | -6.00 | -71.43% |
| 5 Years | 8.40 | 15.55 | 0.9548 | 3.86 | 621,337 | -6.00 | -71.43% |
bioAffinity Technologies Description
| bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers. |
